Yamac Akgun

Yamac Akgun

Auto-generated profile, based on publicly available information

Yamac Akgun

Department of Pathology and Laboratory Medicine University of Miami Miller School of Medicine Miami Florida USA

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

2 January 2026 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
NPNicholas Parisi
Nicholas Parisi
MNMenatalla Nadim
Menatalla Nadim
YAYamac Akgun
Yamac Akgun

15 January 2026 in Transfusion
Verified
Journal Article
Open access
MNMenatalla Nadim
Menatalla Nadim
YAYamac Akgun
Yamac Akgun

23 August 2025 in Hematology, Transfusion and Cell Therapy
Verified
Journal Article
Open access
YBYigit Baykara
Yigit Baykara
KSKaan Sevgi
Kaan Sevgi
YAYamac Akgun
Yamac Akgun
COVID-19-associated thrombotic microangiopathy has emerged as a severe complication that exacerbates morbidity and mortality in critical cases. Thrombotic microangiopathy, characterized by microvascular thrombosis and endothelial injury, includes conditions like thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome. This review investigates therapeutic plasma exchange as a potential strategy to mitigate COVID-19-induced thrombotic microangiopathy, examining its role in removing pro-inflammatory cytokines, immune complexes, and pro-thrombotic factors. Additionally, it highlights the synergistic effects when therapeutic plasma exchange is combined with treatments such as complement inhibitors and immunosuppressants. Preliminary evidence, drawn from case reports and early trials, supports the efficacy of therapeutic plasma exchange in improving outcomes for COVID-19-associated thrombotic microangiopathy. However, larger randomized controlled trials are necessary to definitively establish its place in COVID-19 management, particularly for high-risk and transplant patients with underlying immunological vulnerabilities.

27 February 2025 in Transfusion Clinique et Biologique
Verified
Journal Article
Closed access
APAndriana Pavlovich
Andriana Pavlovich
PBPaxton Barco
Paxton Barco
BCBrian Cook
Brian Cook
APAshley Peck
Ashley Peck
FMFaith Matthews
Faith Matthews
YAYamac Akgun
Yamac Akgun

27 June 2026 in Transfusion and Apheresis Science
Verified
Journal Article
Closed access
MNMenatalla Nadim
Menatalla Nadim
YAYamac Akgun
Yamac Akgun